Ann: Share Purchase Plan Offer Booklet, page-58

2.5% diff from on market price, expected it to be higher than that. Guess read the short term chart wrong.
potentially touches 55c support area post spp? Not that I think will be there for long though, multiple catalysts to come & > $60m cash in bank should help up the sp post mid dec once tranche 2 is done with imho.

short term target .90 in Q1 next yr &
med term target $1.7-$2 come dec 2022 (unless we do a vul of course, which is possible lol).

long term well north of $4

compared to most other specs I hold, this has got to be one I’ve got most confidence in (doesn’t mean sp won’t have its share of falls in line with nickel of course) so my #1 holding. Go big or go home lol